(Q48949605)

17 February 2018

title

Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer. (English)

1 reference

17 February 2018

author name string

Liang Mao

1

1 reference

17 February 2018

Wei-Wei Deng

2

1 reference

17 February 2018

Guang-Tao Yu

3

1 reference

17 February 2018

Lin-Lin Bu

4

1 reference

17 February 2018

Jian-Feng Liu

5

1 reference

17 February 2018

Si-Rui Ma

6

1 reference

17 February 2018

Lei Wu

7

1 reference

17 February 2018

Ashok B Kulkarni

8

1 reference

17 February 2018

Wen-Feng Zhang

9

1 reference

17 February 2018

Zhi-Jun Sun

10

1 reference

17 February 2018

language of work or name

English

0 references

publication date

31 October 2016

1 reference

17 February 2018

International Journal of Cancer

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 February 2018

volume

140

1 reference

17 February 2018

issue

5

1 reference

17 February 2018

page(s)

1173-1185

1 reference

17 February 2018

Oral cavity and oropharyngeal squamous cell carcinoma--an update

cites work

1 reference

21 January 2018

Cancer statistics, 2016

1 reference

The molecular biology of head and neck cancer

21 January 2018

1 reference

Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.

21 January 2018

1 reference

21 January 2018

The hunting of the Src

1 reference

Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model

21 January 2018

1 reference

Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model

21 January 2018

1 reference

The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged

21 January 2018

1 reference

Src family kinases in tumor progression and metastasis

21 January 2018

1 reference

Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.

21 January 2018

1 reference

Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer

21 January 2018

1 reference

Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers

21 January 2018

1 reference

Myeloid-derived suppressor cells as effectors of immune suppression in cancer.

21 January 2018

1 reference

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

21 January 2018

1 reference

CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation

21 January 2018

1 reference

Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway

21 January 2018

1 reference

Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage

21 January 2018

1 reference

Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.

21 January 2018

1 reference

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

21 January 2018

1 reference

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.

21 January 2018

1 reference

Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor

21 January 2018

1 reference

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer

21 January 2018

1 reference

Immunology and Immunotherapy of Head and Neck Cancer

21 January 2018

1 reference

Differential transformation capacity of Src family kinases during the initiation of prostate cancer

21 January 2018

1 reference

Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer

21 January 2018

1 reference

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

21 January 2018

1 reference

Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma

21 January 2018

1 reference

Src kinases as therapeutic targets for cancer

21 January 2018

1 reference

Cholesterol-independent interactions with CD47 enhance alphavbeta3 avidity

21 January 2018

1 reference

Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation

21 January 2018

1 reference

Global epidemiology of oral and oropharyngeal cancer

21 January 2018

1 reference

NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma

21 January 2018

1 reference

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.

21 January 2018

1 reference

LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer

21 January 2018

1 reference

Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.

21 January 2018

1 reference

A systems biology approach identifies effective tumor-stroma common targets for oral squamous cell carcinoma

21 January 2018

1 reference

The tumor microenvironment is a dominant force in multidrug resistance.

21 January 2018

1 reference

Regulation of tumor metastasis by myeloid-derived suppressor cells

21 January 2018

1 reference

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

21 January 2018

1 reference

Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.

21 January 2018

1 reference

Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

21 January 2018

1 reference

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors

21 January 2018

1 reference

Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

21 January 2018

1 reference

A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency

21 January 2018

1 reference

Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.

21 January 2018

1 reference

Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30493

1 reference

17 February 2018

release_4qhbhgp5q5ffbjueniwjjr765y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4qhbhgp5q5ffbjueniwjjr765y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 February 2018